Hans Grönlund's research group

Denna sida på svenska

Therapeutic Immune Design

We focus on diagnostics and curative treatments of chronic inflammatory diseases and cancer. Central to our research is the design and production of proteins for analyses of pathogenic antibodies and immune cells. The goal is to provide novel remedies applicable for clinical use. Therefore we adopt a translational research approach; we have established collaboration with clinicians, SciLife lab, biotechnical and medical companies, as well as academic research groups in Sweden and abroad. All our efforts aim to improve the quality of life for patients.

Gruppen Terapeutisk immundesign

Research projects

  • Autoantigens in multiple sclerosis (MS)
  • Allergenes as tools for diagnosis and treatment of allergic disease
  • Cancer immunotherapy

Read more about the research here

Selected publications

Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.
Neimert-Andersson T, Binnmyr J, Enoksson M, Langebäck J, Zettergren L, Hällgren A, et al
Vaccine 2014 Oct;32(45):5967-74







Group members

Klara AsplundAssociated
Mattias BrongePhD student, Graduate Student
Guro GafvelinSenior researcher
Hans GrönlundSenior researcher, Research team leader
Erik HolmgrenResearch coordinator
Andreas KaiserAssociated
Ana LukicPostdoc
Marta NazzariAssociated
Ola NilssonAssociated
Luigi NotariAssociated
Knut PetterssonAssociated
Claudia QueirozAssociated
Anna WintersandPhD student, Graduate Student